Role of hydroxypropylmethylcellulose (HPMC 4000) in the protection of the polymorphs of piroxicam extended release tablets
dc.contributor.author | Merah, A. | |
dc.contributor.author | Abidi, A. | |
dc.contributor.author | Chaffai, N. | |
dc.contributor.author | Bataille, B. | |
dc.contributor.author | Gherraf, N. | |
dc.date.accessioned | 2022-04-28T01:30:24Z | |
dc.date.available | 2022-04-28T01:30:24Z | |
dc.date.issued | 2013 | |
dc.description.abstract | The present study deals with the influence of hydroxypropylmethylcellulose 4000 in the protection of Piroxicam polymorphs which could appear during the processes of formulation of extended release tablets. The physico-chemical tests and the dissolution profiles of polymorphs and tablets showed that the metolose incorporated in the tablets at a rate equivalent to 5% could possibly act doubly; initially by protecting the piroxicam polymorphism transition (form II) during compression, then modulating its in vitro release (extended release). | ar |
dc.identifier.uri | http://hdl.handle.net/123456789/13037 | |
dc.language.iso | en | ar |
dc.publisher | Springer | ar |
dc.subject | Piroxicam | ar |
dc.subject | Polymorphism | ar |
dc.subject | Hydroxypropylmethylcellulose 4000 | ar |
dc.subject | Crystallization | ar |
dc.subject | Extended release | ar |
dc.title | Role of hydroxypropylmethylcellulose (HPMC 4000) in the protection of the polymorphs of piroxicam extended release tablets | ar |
dc.type | Article | ar |
Files
Original bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- role-of-hydroxypropylmethylcellulose.pdf
- Size:
- 1.52 MB
- Format:
- Adobe Portable Document Format
- Description:
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 1.71 KB
- Format:
- Item-specific license agreed upon to submission
- Description: